Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment

1 May 2024

Abstract excerpt

Breast cancer (BC) is the most widespread cancer worldwide. Over 2 million new cases of BC were identified in 2020 alone. Despite previous studies, the lack of specific biomarkers and signaling pathways implicated in BC impedes the development of potential therapeutic strategies. We employed several RNAseq datasets to extract differentially expressed genes (DEGs) based on the intersection of all datasets,...

Topics

Join the communities discussing this publication.

Cancer Mechanisms and Therapy
Epigenetics and DNA Methylation
Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38717954
DOI: 10.1002/cnr2.2009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatmentPMID 38717954Read ↗

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity Read ↗

Breast cancer genomic analyses reveal genes, mutations, and signaling networks.Semantic proximity Read ↗

Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic MarkersSemantic proximity Read ↗

Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical CancerSemantic proximity Read ↗

OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicineSemantic proximity Read ↗

Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools.Semantic proximity Read ↗

Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validationSemantic proximity Read ↗

Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysisSemantic proximity Read ↗

OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine.Semantic proximity Read ↗

Breast cancer biomarkers identified in the Gene Expression Omnibus and The Cancer Genome AtlasSemantic proximity Read ↗

Functional genomics for breast cancer drug target discoverySemantic proximity Read ↗

Prediction of breast cancer proteins involved in immunotherapy, metastasis, and RNA-binding using molecular descriptors and artificial neural networksSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.